Registration 333-290778
Underwriters: ThinkEquity LLC
Company research
CIK 1776612Updated Oct 6, 2026
8 filings on record · FWP, S-1/A.
We are a pet biotechnology company focused on the development and commercialization of innovative biopharmaceutical products for cats, dogs, and other companion animals. We believe the pet health market is experiencing rapid growth, with increasing demand for innovative treatments that enhance pet longevity and quality of life. According to the American Pet Products Association, U.S. consumers spent an estimated $152 billion on their pets in 2024. Within this total, the veterinary care and pharmaceutical sales segment accounted for $39.8 billion. A key driver of this growth has been the companion animal therapeutics segment, which has expanded from $12.5 billion in 2015 to a projected $23.7 billion in 2025, representing a compound annual growth rate of 6.6%. Our current product portfolio includes multiple product candidates consisting of large molecule biologics that are designed to target significant opportunities in serious medical conditions in pets such as urothelial carcinoma (bladder cancer) in dogs, atopic dermatitis in dogs, chronic pain associated with arthritis in dogs, and obesity and metabolic disease in cats.
Underwriters: ThinkEquity LLC
Exhibit 4.1 ★ D EL AWA R E ★ SEAL AKSTON BIOSCIENCES CORPORAT OI N CORPORATE DECEMBER 28, 2011 FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK, $0.000001 PAR VALUE PER SHARE, OF Akston Biosciences Corporation transferable on the books of the Corporation in person or by duly authorized attorney upon surrender of this Certificate properly endorsed. This Certificate is not valid until countersigned by the Transfer Agent and registered by the Registrar. WITNESS the facsi…
Read attachment ↗Exhibit 4.2 Form of Representative’s Warrant Agreement THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) THINKEQUITY LLC, OR …
Read attachment ↗Exhibit 4.3 AKSTON BIOSCIENCES CORPORATION REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 21, 2025, is entered into by and among Akston Biosciences Corporation, a Delaware corporation (the “Company”), and the investors signatory hereto (individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors The Company and the Investors may be referred to herein each as a “Party” and collectively…
Read attachment ↗